Page 3 - Cell Lines News Today

/PRNewswire/ -- The "Germany Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to...

Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes...

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply.

Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type...

Cytiva and the life sciences business of Pall Corporation are now united as one business under the Cytiva brand, with the completion of the integration announced this morning. Emmanuel Ligner, Danaher Group Executive, President and CEO of Cytiva, tells us how the company will focus its efforts moving forward to support long-term growth of the biotech industry.

/PRNewswire/ -- The "Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Products & Services...

Bryant Godfrey from law firm Foley Hoag reflects on the progress of cultivated meat production and what challenges remain on the US regulatory landscape.

Bryant Godfrey reflects on the progress of cultivated meat production and what challenges remain on the US regulatory landscape.

To adapt that virus to those cell lines. so it makes sense that the research was working towards a vaccine against coronavirus. maybe a live attenuated vaccine. its all about adapting that virus and growing it in cell lines. its possible these lab accidents do happen. they are unfortunate and thats why all of us who work in the lab are extraordinarily careful. >> i think they happen more commonly than people think. i think this has brought a lot of attention to it. dr. redfield was criticized wh...

Its significant they have gone out of their way to update it? >> i do. the reason its low confidence is because there is no transparency about what china was actually working on. samples from the laboratory. most importantly, those early human samples. lets be realistic about this. we have learned a lot about this virus. soond we know that in order to have high numbers of hospitalizations, the virus had to be circulating in the community for long periods of time. weeks. and we have seen that ove...